Glory Health to Hold Board Meeting on 31 August 2026 for H1 Results and Interim Dividend Deliberation
Bulletin Express
Aug 19
Glory Health Industry Limited announced that its board of directors will convene on 31 August 2026. The agenda includes reviewing and approving the unaudited interim results for the six months ended 30 June 2026 and determining whether to recommend an interim dividend.
The meeting will also authorize the publication of the interim financial report. The announcement was signed by Chairman Zhang Zhangsun in Beijing on 19 August 2026.
As of the announcement date, the board comprises five executive directors—Zhang Zhangsun, Ruan Wenjuan, Yuan Haibin, Zhao Yuhong, and Zhang Xiaoqian—alongside three independent non-executive directors: Chen Jinrong, Deng Zhidong, and Wang Shiyu.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.